• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Who's Who In Cannabis: January Executive Changes You Should Know About

    2/2/24 11:01:13 AM ET
    $FLGC
    $GRIN
    $OGI
    $SBIG
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Marine Transportation
    Consumer Discretionary
    Get the next $FLGC alert in real time by email

    Cannabis And Hemp Regulatory Appointments

    Last week, Flora Growth Corp. (NASDAQ:FLGC) announced that Clifford Starke, its CEO and director, has been elected to serve as chairman of the U.S. Hemp Roundtable board of directors. Starke said "momentum is swinging in the right direction" for hemp and cannabis, "given the current political environment."

    Illinois Gov. J.B. Pritzker announced on Friday new appointments in his administration.

    Besides naming Wendy Epstein as a member of the Illinois Health Benefits Exchange Advisory Committee and Melody Spann Cooper as a member of the Illinois Liquor Control Commission, Pritzker tapped Teresa Ramirez to serve as a member of the Employment Security Board of Review.

    Ramirez has more than two decades of experience as an advocate for workers throughout the Illinois. She's an officer of Local 881 UFCW, currently serving more than 34,000 retail and grocery members as recorder and as the director of organizing, bringing vital union protections to cannabis workers statewide.

    Top Cannabis Companies Name New CEOs, President

    In the meantime, two cannabis giants named new CEOs in January. 4Front Ventures Corp. (CSE:FFNT) (OTCQX:FFNTF) kicked off 2024 by appointing Andrew Thut as CEO, succeeding Leo Gontmakher who remained on the board as a director and served as a consultant to the company.

    The Cannabist Company Holdings Inc. (NEO: CBST) (OTCQX:CBSTF) (FSE: 3LP) announced a week later that the company's board of directors has named David Hart, previously the company's president and chief operating officer, as the new CEO. The board also appointed Jesse Channon, previously the company's chief commercial officer, as president.

    See Also: Who’s Who In Cannabis: Latest Executive Changes You Should Know About

    Board Changes

    In January, four companies made changes to their respective boards of directors.

    Rythmia Life Advancement Center, a medically licensed plant medicine-based personal transformation center, announced the appointment of entrepreneur Earl Koskie to its board of directors.

    Organigram Holdings Inc. (TSX:OGI) (NASDAQ:OGI) appointed Karina Gehring to its board at the company's annual general and special meeting held on Jan. 18. Gehring is one of two directors (including Simon Ashton) designated by BT DE Investments Inc., a wholly-owned subsidiary of British American Tobacco plc, as nominees to the company's board. She has over 25 years of experience in marketing and trade at BAT.

    California-focused, vertically integrated cannabis company, StateHouse Holdings Inc. (CSE:STHZ) (OTCQB:STHZF) said recently that J. Roy Pottle resigned from its board of directors, to pursue other opportunities.

    SpringBig Holdings, Inc. (OTCQX:SBIG), a provider of SaaS-based marketing solutions for cannabis companies, announced on Monday changes in its board of directors following the completion of its $8 million debt financing with a syndicate of lenders. Matt Sacks, a co-managing partner of Lightbank, and Shawn Dym, a co-lead investor in the debt financing through Shalcor Management Inc., have both joined the company's board of directors.

    Now read: Latest Cannabis Hires: Three New CEOs And More

    Other Leadership Changes In Cannabis Industry

    MedMen Enterprises Inc. (CSE:MMEN) (OTCQX:MMNFF) said last week that Ellen Deutsch Harrison has stepped down as the CEO and a board member, after which the board appointed Richard Ormond as chief restructuring officer. Moreover, Michael Serruya, executive chairman of the board, who has served in this position since August 2021, has stepped down from the board effective today.

    BZAM Ltd. (CSE:BZAM) (OTC:BZAMF) announced last week that Sean Bovingdon, chief financial officer, opted to leave his position on April 30, 2024, to pursue other opportunities. In conjunction with the transition, Bovingdon agreed to step down from the board of directors effective immediately, while Matt Milich, the company's CEO, agreed to join it to fill the vacancy.

    California cannabis producer Lehua Brands welcomed four executives to its team earlier this month, as part of an expansion of its house of brands into Canada, including CEO Sierra Elaina, Vice President of Development Todd Menaker, Vice President of Operations Thomas Riddle and Director of Marketing Yorgi Spanos.

    Trulieve Cannabis Corp. (CSE:TRUL) (OTC:TCNNF) has named Marie Zhang as its new chief operating officer, effective Monday, Jan. 29, 2024. Zhang has more than 25 years of experience in operational roles for private and public companies including Blaze Pizza, Focus Brands, Yum! Brands and ConAgra Foods.

    Grown Rogue International Inc. (CSE:GRIN) (OTC:GRUSF) announced recent changes to its management team, including the promotion of Christian Stiers to national cultivation director and Seann Igoe to national post-harvest director. In addition, Cameron Correia was hired as the company's newly established vice president of business analytics, while Kala Bernhardt joined the executive team as corporate controller.

    Simply Solventless Concentrates Ltd. (TSXV:HASH) appointed Jeff Lawrence to the position of vice president of marketing and sales last week.

    Consensus Holdings Arizona, a manufacturing and distribution company in the cannabis industry, has named Leah Sigety as its new chief operating officer.

    The American Association for Laboratory Accreditation (A2LA), a global accreditation body, hired Scott Renkes as its new business development manager. As the latest addition to the business development team, Renkes is expected to create high-level business development strategies and work closely with prospective A2LA customers.

    Benzinga Cannabis Conferences are coming to Los Angeles. Join the Benzinga Cannabis Market Spotlight: California, and unlock the future of cannabis at the premier networking event in Culver City on Feb. 22.

    Connect with top industry leaders, gain insider insights into the investment landscape and shape the evolving markets in California and beyond. Don't miss this chance to be at the forefront of the cannabis industry's growth and innovation! Join now.

    Photo: Courtesy of geralt, lindsayfox Pixabay

    Get the next $FLGC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FLGC
    $GRIN
    $OGI
    $SBIG

    CompanyDatePrice TargetRatingAnalyst
    Organigram Global Inc.
    $OGI
    1/27/2026Buy
    Canaccord Genuity
    Flora Growth Corp.
    $FLGC
    11/25/2024$4.00Buy
    Aegis Capital
    Organigram Global Inc.
    $OGI
    7/17/2024Speculative Buy
    Canaccord Genuity
    Organigram Global Inc.
    $OGI
    4/15/2024Neutral → Buy
    Alliance Global Partners
    Grindrod Shipping Holdings Ltd.
    $GRIN
    10/16/2023Buy → Neutral
    Alliance Global Partners
    Grindrod Shipping Holdings Ltd.
    $GRIN
    7/17/2023$12.50Neutral → Buy
    Alliance Global Partners
    Organigram Global Inc.
    $OGI
    1/13/2023Hold → Buy
    Stifel
    Grindrod Shipping Holdings Ltd.
    $GRIN
    8/3/2022$32.00Buy
    Alliance Global Partners
    More analyst ratings

    $FLGC
    $GRIN
    $OGI
    $SBIG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Zeifman Laurence

    3 - Flora Growth Corp. (0001790169) (Issuer)

    1/15/26 11:54:20 AM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by CFO Vaiman Dany

    4 - Flora Growth Corp. (0001790169) (Issuer)

    12/22/25 5:15:05 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by CEO Reis-Faria Daniel

    4 - Flora Growth Corp. (0001790169) (Issuer)

    12/22/25 5:13:21 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FLGC
    $GRIN
    $OGI
    $SBIG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Organigram Reports First Quarter Fiscal 2026 Results

    Strong year-over-year growth supported by Canadian leadership and growing international sales, improving gross margin. Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share1, is pleased to announce its results for the first quarter ended December 31, 2025 ("Q1 Fiscal 2026" or "Q1"). Q1 FISCAL 2026 HIGHLIGHTS Gross Revenue: $97.3 million (+46% year-over-year). Net Revenue: $63.5 million (+49% year-over-year). International Revenue: $5.0 million (+51% year-over-year). Adjusted EBITDA2: $5.3 million (+273% year-over-year). #1 Market Share in Canada: #1 in vapes, #1 in milled flower, #1 in concentrates, #2

    2/10/26 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Organigram to Report First Quarter Fiscal 2026 Results on February 10, 2026

    Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share, announced today it will report earnings results for its first quarter fiscal 2026 ended December 31, 2025, on Tuesday, February 10, 2026, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, February 10, 2026 Time: 8:00 am Eastern Time To register for the conference call, please use this link: https://events.q4inc.com/analyst/430252525?pwd=WEt2KbHS To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before the start of the call.

    2/3/26 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Flora Growth Corp. Announces Name Change to ZeroStack Corp., Furthering Its Strategy as an AI-Focused Asset Management Company

    Toronto, Ontario--(Newsfile Corp. - January 27, 2026) - Flora Growth Corp. (NASDAQ:FLGC) (the "Company") today announced that it will change its corporate name to "ZeroStack Corp." The name change is expected to become effective on or around January 29, 2026, on the Nasdaq Capital Market (the "Nasdaq"). Concurrent with the corporate name change, the Company's common shares (the "Common Shares") will trade on the Nasdaq under the symbol "ZSTK".The name and ticker change reflect the Company's evolution toward an AI-focused, asset management strategy with its first investment in $0G, the native asset of the 0G decentralized AI operating system ("0G Token").ZeroStack is focused on providing expo

    1/27/26 8:00:00 AM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FLGC
    $GRIN
    $OGI
    $SBIG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Sykes Paul bought $900 worth of shares (15,000 units at $0.06), increasing direct ownership by 3% to 550,350 units (SEC Form 4)

    4 - SpringBig Holdings, Inc. (0001801602) (Issuer)

    11/19/24 4:36:58 PM ET
    $SBIG
    EDP Services
    Technology

    CEO Starke Clifford bought $6,455 worth of shares (6,795 units at $0.95), increasing direct ownership by 13,324% to 6,846 units (SEC Form 4)

    4 - Flora Growth Corp. (0001790169) (Issuer)

    9/17/24 10:17:39 AM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Wolkin Harold bought $24,255 worth of shares (25,000 units at $0.97) (SEC Form 4)

    4 - Flora Growth Corp. (0001790169) (Issuer)

    9/11/24 5:43:51 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FLGC
    $GRIN
    $OGI
    $SBIG
    SEC Filings

    View All

    SEC Form 6-K filed by Organigram Global Inc.

    6-K - ORGANIGRAM GLOBAL INC. (0001620737) (Filer)

    2/10/26 7:41:44 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SpringBig Holdings Inc. filed SEC Form 8-K: Leadership Update

    8-K - SpringBig Holdings, Inc. (0001801602) (Filer)

    2/6/26 9:33:52 AM ET
    $SBIG
    EDP Services
    Technology

    SEC Form 6-K filed by Organigram Global Inc.

    6-K - ORGANIGRAM GLOBAL INC. (0001620737) (Filer)

    2/3/26 11:10:05 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FLGC
    $GRIN
    $OGI
    $SBIG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on Organigram Global

    Canaccord Genuity initiated coverage of Organigram Global with a rating of Buy

    1/27/26 9:29:20 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Aegis Capital initiated coverage on Flora Growth with a new price target

    Aegis Capital initiated coverage of Flora Growth with a rating of Buy and set a new price target of $4.00

    11/25/24 8:07:10 AM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Canaccord Genuity resumed coverage on OrganiGram

    Canaccord Genuity resumed coverage of OrganiGram with a rating of Speculative Buy

    7/17/24 12:18:49 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FLGC
    $GRIN
    $OGI
    $SBIG
    Leadership Updates

    Live Leadership Updates

    View All

    Organigram Announces Appointment of Chief Executive Officer

    Organigram Global Inc. ("Organigram" or the "Company") (TSX:OGI) (NASDAQ:OGI), the parent company of Organigram Inc., a leading Canadian producer of cannabis, is pleased to announce that James Yamanaka, formerly Global Head of Strategy for British American Tobacco, has been appointed the Company's new Chief Executive Officer (CEO). Mr. Yamanaka is expected to assume the role effective on or about January 15, 2026. Mr. Yamanaka will also join the Company's board of directors when he assumes the role of Chief Executive Officer. Mr. Yamanaka is a seasoned executive, having spent more than 20 years at British American Tobacco, with extensive experience in strategy and general management across

    11/25/25 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Springbig Reports Third Quarter 2025 Results – Achieves Profitability, Extends Streak of Positive Adjusted EBITDA*

    Returned to Profitability with Net Income of $0.2MThird Consecutive Quarter of Positive Adjusted EBITDARevenue Rises to $5.9M, with AI Integration and Cost Controls Driving Efficiency BOCA RATON, Fla., Nov. 14, 2025 (GLOBE NEWSWIRE) -- SpringBig Holdings, Inc. (OTCQB:SBIG) ("Springbig" or the "Company"), a leading provider of AI-powered MarTech solutions for regulated industries, today reported financial results for the third quarter ended September 30, 2025. "Q3 marked a key milestone for Springbig, as we again achieved positive net income while maintaining strong operating discipline and margin improvement," said Jaret Christopher, Chief Executive Officer and Chairman of Springbig. "Th

    11/14/25 9:00:00 AM ET
    $SBIG
    EDP Services
    Technology

    SRx Health Solutions Appoints Sammy Dorf to Board of Directors

    TAMPA, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced the appointment of Sammy Dorf, Esq. to its Board of Directors. Sammy is a pioneering force in the modern cannabis economy and one of the industry's most accomplished dealmakers, strategists, and growth architects. Most recently serving as Executive Chairman of Flora Growth Corp. (NASDAQ:FLGC), Sammy guided the company through a transformative phase marked by innovation, disciplined expansion, and a strategic transition into a crypto treasury company. With nearly a decade of leadership at the intersection of cannabis, capital markets, and strategic development, Sammy b

    11/10/25 8:00:00 AM ET
    $FLGC
    $SRXH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Beverages (Production/Distribution)
    Consumer Staples

    $FLGC
    $GRIN
    $OGI
    $SBIG
    Financials

    Live finance-specific insights

    View All

    Organigram Reports First Quarter Fiscal 2026 Results

    Strong year-over-year growth supported by Canadian leadership and growing international sales, improving gross margin. Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share1, is pleased to announce its results for the first quarter ended December 31, 2025 ("Q1 Fiscal 2026" or "Q1"). Q1 FISCAL 2026 HIGHLIGHTS Gross Revenue: $97.3 million (+46% year-over-year). Net Revenue: $63.5 million (+49% year-over-year). International Revenue: $5.0 million (+51% year-over-year). Adjusted EBITDA2: $5.3 million (+273% year-over-year). #1 Market Share in Canada: #1 in vapes, #1 in milled flower, #1 in concentrates, #2

    2/10/26 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Organigram to Report First Quarter Fiscal 2026 Results on February 10, 2026

    Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share, announced today it will report earnings results for its first quarter fiscal 2026 ended December 31, 2025, on Tuesday, February 10, 2026, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, February 10, 2026 Time: 8:00 am Eastern Time To register for the conference call, please use this link: https://events.q4inc.com/analyst/430252525?pwd=WEt2KbHS To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before the start of the call.

    2/3/26 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Organigram Reports Record Fourth Quarter and Fiscal 2025 Results

    Record annual revenue, adjusted EBITDA1, and international sales. Organigram Global Inc (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 recreational cannabis company by market share2, is pleased to announce record results for the fourth quarter and twelve months ended September 30, 2025 ("Q4 Fiscal 2025" or "Fiscal 2025"). All financial information in this press release is expressed in Canadian dollars ("$"). FOURTH QUARTER 2025 FINANCIAL HIGHLIGHTS Gross Revenue: $123.3 million (+76% year-over-year). Net Revenue: $80.1 million (+79% year-over-year). Adjusted Gross Margin1: $30.6 million or 38%. Adjusted EBITDA1: $9.8 million (+69% year-over-year). FISCAL 20

    12/16/25 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FLGC
    $GRIN
    $OGI
    $SBIG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

    SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

    12/17/24 8:02:53 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

    SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

    12/17/24 8:01:40 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Organigram Holdings Inc.

    SC 13D/A - ORGANIGRAM HOLDINGS INC. (0001620737) (Subject)

    12/10/24 7:10:15 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care